Sponsor Pipeline

TORL Biotherapeutics, LLC Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
8
Active Trials
5
Recruiting
7
Disease Areas
Active Trials by Phase
Phase 2
1
Phase 1/2
2
Phase 1
5
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06690775 CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer. Epithelial Ovarian Cancer Recruiting
Phase 1/2
NCT07439653 A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma Histologically Confirmed Relapsed or Refractory B-cell Non-Hodgkin Lymphoma Recruiting
NCT07322094 CATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy… FIGO Stage III and IV Ovarian Cancer Recruiting
Phase 1
NCT06005740 A Phase 1, First in Human Study of TORL-4-500 in Patients With Advanced Cancer Advanced Solid Tumor Recruiting
NCT05103683 First in Human Study of TORL-1-23 in Participants With Advanced Cancer Advanced Solid Tumor Recruiting
NCT05159440 First in Human Study of TORL-2-307-MAB in Participants With Advanced Cancer Advanced Solid Tumor Active, Not Recruiting
NCT05948826 First in Human Study of TORL-3-600 in Participants With Advanced Cancer Advanced Solid Tumor Active, Not Recruiting
NCT05156866 First in Human Study of TORL-2-307-ADC in Participants With Advanced Cancer Advanced Solid Tumor Active, Not Recruiting
Disease Areas
Get alerts when TORL Biotherapeutics, LLC's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free